On Friday, May 22 NIH issued NOT-OD-20-110 with updated information on the reissuance of certain parent FOAs and Forms-F packages.
NIH is continuing to reissue Parent FOAs for Forms-F implementation. It is anticipated that reissuance of all Parent FOAs will be completed by June 25, 2020. Some updates have been made in the interim.
The following Parent FOAs have not yet been reissued, but Forms-F packages have been added to the existing FOAs:
- PA-18-589 Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- PA-18-590 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
- PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp – Clinical Trial Optional)
- PA-18-592 Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp – Clinical Trial Not Allowed
The following Parent FOAs have not yet been reissued, nor have Forms-F packages been added to the existing FOAs (you may continue to use Forms-E until they are reissued):
- PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)
- PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)
Please review the full Notice, and contact the Grant Officer/Analyst for your department or erahelp@research.ucla.edu if you have questions. Click here for a full list of Parent FOAs.